Women & Infants Hospital of Rhode Island

Care New England Taps Kyndryl to Help Improve Patient Care

Retrieved on: 
Tuesday, August 15, 2023
Software, General Health, Health, Data Management, Health Technology, Technology, Other Technology, Security, Women & Infants Hospital of Rhode Island, Amazon Web Services, Care New England, Partnership, EMR, KD, NYSE, Hospital, MD, Patient, Investment, Nonprofit organization, Growth, Woman, Environment, AWS, Automation, Nursing, Renewable energy

The goal of this program is to improve productivity and enable more coordinated and efficient patient care.

Key Points: 
  • The goal of this program is to improve productivity and enable more coordinated and efficient patient care.
  • Care New England will also leverage Kyndryl’s strategic partnership with Amazon Web Services (AWS) to migrate critical workloads, including its EMR system, onto the AWS cloud.
  • “We’re thrilled to join forces with Kyndryl in supporting Care New England throughout their digital transformation journey.”
    Importantly, many Care New England employees will join Kyndryl’s team and continue to provide technical services to Care New England.
  • Care New England will join the 500 global customers currently operational on Kyndryl Bridge and will leverage the expertise of Kyndryl Consult, Kyndryl Vital and Kyndryl’s Clinical Experience Team to identify new ways to improve the patient and caregiver experience.

Unite Us Celebrates a Year of Nationwide Impact, Improving Cross-Sector Collaboration and Quality of Life for 18.7M Americans To Date

Retrieved on: 
Thursday, January 12, 2023
Well, Faith Divides Us – Death Unites Us, Entrepreneurship, Caregiver, Paralyzed Veterans of America, Government, Woman, Centers for Medicare & Medicaid Services, Food, Andrew Kohut, SNAP, Date, Housing, CMS, Case management (US healthcare system), Health, BIPOC, Organization, Health equity, Veteran, United States Public Health Service, Georgia Department of Defense, Women & Infants Hospital of Rhode Island, Infant, Software, Supplemental Nutrition Assistance Program, Social support, Richard Barker (life sciences and healthcare leader), School, SNS, Child, Quality of life, Arizona Department of Veterans' Services, Risk, Medicare, WIC, Equal employment opportunity, Health insurance, Management, Becker, Health care, Hunger

NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Unite Us, the nation's leading software company enabling cross-sector collaboration announced it has impacted and improved the health and well-being of more than 18.7 million people since the 2013 launch of its software, bringing together healthcare, government, nonprofit, and private-sector partners to address social determinants of health (SDoH).

Key Points: 
  • "We've seen an increased need for social support across the country this year," said Dan Brillman, Co-Founder and CEO at Unite Us.
  • "I'm extremely proud of our team for rising to the occasion, readily creating capacity and building efficiency for our partners.
  • Most notably, the Unite Us Platform has driven year-over-year improvement in:
    Partnering with maternal and child well-being through programs like First 1,000 Days Suncoast.
  • To learn more about Unite Us' SDoH software and social care infrastructure, visit www.UniteUs.com .

MEDICA 2022 Newcomer: Scivita Medical celebrates trade show success and the strategy of "globalization"

Retrieved on: 
Monday, November 21, 2022
Medicine, Innovation, Endoscopy, FDA, UHD, Women & Infants Hospital of Rhode Island, International, Fujifilm, Medtech, Research, Patient, PDMA, Single, COVID-19, European, Hospital, MEDICA, Child, Product life-cycle theory, Diagnosis, Collaborative innovation network, Medical device

DUSSELDORF, Germany, Nov. 20, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair.

Key Points: 
  • DUSSELDORF, Germany, Nov. 20, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair.
  • Scivita Medical is a global medical technology company for minimally invasive diagnostic, establishing R&D centers in both China and Japan.
  • Besides, Scivita Medical has obtained FDA-/CE- and PDMA-certifications for their products and applied patents in China as well as overseas.
  • Driven by the goal of integrating research and development in medical technology, Scivita Medical is cooperating with many clinics and medical centers.

MEDICA 2022 Newcomer: Scivita Medical celebrates trade show success and the strategy of "globalization"

Retrieved on: 
Monday, November 21, 2022
Medicine, Innovation, Endoscopy, FDA, UHD, Women & Infants Hospital of Rhode Island, International, Fujifilm, Medtech, Research, Patient, PDMA, Single, COVID-19, European, Hospital, MEDICA, Child, Product life-cycle theory, Diagnosis, Collaborative innovation network, Medical device

DUSSELDORF, Germany, Nov. 21, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair.

Key Points: 
  • DUSSELDORF, Germany, Nov. 21, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair.
  • Scivita Medical is a global medical technology company for minimally invasive diagnostic, establishing R&D centers in both China and Japan.
  • Besides, Scivita Medical has obtained FDA-/CE- and PDMA-certifications for their products and applied patents in China as well as overseas.
  • Driven by the goal of integrating research and development in medical technology, Scivita Medical is cooperating with many clinics and medical centers.

Perrigo Announces Strategic Investment to Expand and Strengthen U.S. Manufacturing of Infant Formula

Retrieved on: 
Tuesday, November 1, 2022
Marketing, Consumer, Risk, CEO, Health, Natural borrowing limit, NYSE, PRGO, Industry, COVID-19, Intention, Women & Infants Hospital of Rhode Island, Infant, No Good (Start the Dance), WIC, Contract, Coronavirus, Government, Terminology, Good, Sale, Investment, U.S. Securities and Exchange Commission, OTC, Caregiver, Snack, Parent, Toy, Risk management, Gateway, Gerber, Company, Perrigo

DUBLIN, Nov. 1, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or "the Company") today announced a $170 million strategic investment to expand and strengthen its U.S. infant formula manufacturing, which is expected to bolster industry capacity, enhance consumer choice and increase access to safe, affordable infant formula for parents and caregivers. As part of this strategic investment, Perrigo has purchased Nestlé's Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the Good Start® infant formula brand. Also included in the $170 million, Perrigo will immediately invest $60 million to expand Gateway's 29 million pound per year production capacity by 7 million pounds, or more than 100 million more 8-ounce bottle equivalents per year, within 18 months, adding a total of 36 million pounds of capacity to Perrigo. These investments are in addition to the approximately $20 million Perrigo invests each year to ensure a safe, high-quality supply of infant formula from its Vermont and Ohio infant formula facilities.

Key Points: 
  • Company Purchases Nestl's Gateway Infant Formula Plant in Eau Claire, Wisconsin, along with U.S. and Canadian rights to the Good Start Infant Formula Brand
    DUBLIN, Nov. 1, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or "the Company") today announced a $170 million strategic investment to expand and strengthen its U.S. infant formula manufacturing, which is expected to bolster industry capacity, enhance consumer choice and increase access to safe, affordable infant formula for parents and caregivers.
  • As part of this strategic investment, Perrigo has purchased Nestl's Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the Good Start infant formula brand.
  • These investments are in addition to the approximately $20 million Perrigo invests each year to ensure a safe, high-quality supply of infant formula from its Vermont and Ohio infant formula facilities.
  • It solidifies our long-term manufacturing supply of infant formula in the U.S., increases the availability of lower priced, high-quality infant formula to consumers, and delivers value to Perrigo shareholders."

Teross Young Receives Georgia Food Industry Association’s Legacy Award for Commitment to Industry and Community

Retrieved on: 
Wednesday, August 31, 2022
Public Affairs Council, Legislation, Supplemental Nutrition Assistance Program, The Giant Company, Stop & Shop, Director, Volunteering, Government, Women & Infants Hospital of Rhode Island, Giant Food, Food Lion, GLOBE, SNAP, Hurston-Wright Legacy Award, Ahold Delhaize, FMI, Industry, Food industry, WIC, Love, Family, Grocery store, Woman

QUNICY, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Teross Young, Vice President, Government and Regulatory Affairs for Ahold Delhaize USA, recently received the Georgia Food Industry Associations (GFIA) 2022 Legacy Award, which was presented at the organizations 2022 convention in Orlando, Fla.

Key Points: 
  • QUNICY, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Teross Young, Vice President, Government and Regulatory Affairs for Ahold Delhaize USA, recently received the Georgia Food Industry Associations (GFIA) 2022 Legacy Award, which was presented at the organizations 2022 convention in Orlando, Fla.
  • The award is presented each year to honor an individual who has made a measurable difference in their community and to the food industry.
  • I was surprised and amazed that my peers in the organization and industry would recognize the work Ive done over the past 20 years, Young said.
  • In addition to his professional and board service, Young volunteers with his church, fraternity and in his local community.

Caroline Maria Skudlarek, DO, FACOG, FACOOG, is recognized by Continental Who's Who

Retrieved on: 
Wednesday, May 18, 2022
Osteopathy, American College, American Osteopathic Board of Obstetrics and Gynecology, American College of Obstetricians and Gynecologists, Patient, Lutheran Medical Center, AOBOG, DO, Suite, Women & Infants Hospital of Rhode Island, Woman, FACOG, Georgetown University, Osteopathic medicine in the United States, Continental, Medicine, Veterinary medicine, Science, Biology, Obstetrics, Gynaecology

Her medical practice is located at 235 Plain St., Suite 401, in Providence, RI.

Key Points: 
  • Her medical practice is located at 235 Plain St., Suite 401, in Providence, RI.
  • Widely known as a compassionate doctor, Dr. Skudlarek works closely with her patients, listening carefully to them and fully addressing any concerns they may have.
  • She explains, "Osteopathic medicine combines all the science of today's medical technology and understanding with a hands-on approach taught during osteopathic training."
  • Dr. Skudlarek is board-certified in Obstetrics and Gynecology by the American Osteopathic Board of Obstetrics and Gynecology (AOBOG).

RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia

Retrieved on: 
Monday, September 27, 2021
ISO, Gestational age, Clinical, Randomized controlled trial, FDA, Patient, Patient satisfaction, Shanghai, CSEA, CEO, BMI, Paresthesia, Risk, RCT, Journal, Women & Infants Hospital of Rhode Island, Learning curve, Blood, Safety, Body mass index, Palpation, GLOBE, Medical imaging

"Numerous studies have confirmed the effectiveness and safety of the Accuro-guided technique over the palpation-based approach for spinal placement or epidural catheterization," commented Will Mauldin, Ph.D., co-founder and CEO of RIVANNA.

Key Points: 
  • "Numerous studies have confirmed the effectiveness and safety of the Accuro-guided technique over the palpation-based approach for spinal placement or epidural catheterization," commented Will Mauldin, Ph.D., co-founder and CEO of RIVANNA.
  • "This study is notable because it detailed a statistically significant reduction in paresthesia, a complication which has not been studied specifically in prior Accuro trials."
  • The use of pre-procedure ultrasound has been associated with a reduced risk of failed epidural analgesia and complications.
  • Providers with even minimal ultrasound experience can take advantage of Accuro's safety benefits and effective image guidance.

OvaryIt Attracts Industry Leaders to Board of Advisors

Retrieved on: 
Wednesday, August 11, 2021
Women & Infants Hospital of Rhode Island, Machine learning, Woman, Legislation, Rhode Island Hospital, Patient, Stanford University Medical Center, OBGYN, Neonatology, Pfizer, American College, Patient safety, American College of Obstetricians and Gynecologists, Organization, Time, Hotel manager, Brown University, Council, Rhode Island, The Biodesign Institute, Assistant, UCSF, Multimedia, Quality, Committee, Center, Johnson & Johnson, MD, American Medical Association, Stanford University, Medicine, Pharmaceutical industry

TALLAHASSEE, Fla., Aug. 11, 2021 /PRNewswire/ -- OvaryIt Holdings, Inc., a women's telehealth company, announces their advisory board as they continue to expand services to additional states.

Key Points: 
  • TALLAHASSEE, Fla., Aug. 11, 2021 /PRNewswire/ -- OvaryIt Holdings, Inc., a women's telehealth company, announces their advisory board as they continue to expand services to additional states.
  • OvaryIt uses its proprietary rules-based engine with layered machine learning to help patients find the hormonal or non-hormonal contraceptive they're most likely to tolerate.
  • Heather A Smith, MD MPH, is an Obstetrician/ Gynecologist at Women & Infants Hospital.
  • Arkady Rubin, Ph.D. is a researcher with 30 years of pharmaceutical industry experience, including 7.5 years at Johnson & Johnson and five years at Pfizer.

Stanford Children's Health Appoints Rick Majzun Vice President and COO

Retrieved on: 
Monday, September 9, 2019
Brown University, Lucile Packard Children's Hospital, Stanford University, California, Women & Infants Hospital of Rhode Island, Children's Health, States of the United States, Mariann Byerwalter, Stanford University Medical Center

STANFORD, Calif., Sept. 9, 2019 /PRNewswire/ --Stanford Children's Health today announced that Rick Majzun has been named vice president and chief operating officer of Stanford Children's Health.

Key Points: 
  • STANFORD, Calif., Sept. 9, 2019 /PRNewswire/ --Stanford Children's Health today announced that Rick Majzun has been named vice president and chief operating officer of Stanford Children's Health.
  • Effective immediately, Majzun will be responsible for providing administrative leadership and direction of the operations of Lucile Packard Children's Hospital Stanford and all of the Stanford Children's Health primary care and specialty services outpatient locations.
  • "Having served more than two decades as an academic health care leader, much of which has been dedicated to the care of women and children, Rick is poised to make a tremendous impact at Stanford Children's Health, and I am thrilled to welcome him to the organization," said Paul King, president and CEO of Stanford Children's Health.
  • Most recently, Majzun served as president and chief operating officer for Women & Infants Hospital in Providence, Rhode Island.